Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions
about
Involvement of aspartoacylase in tremor expression in rats.Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature.Clinical applications involving CNS gene transfer.A Novel Mutation in Aspartoacylase Gene; Canavan Disease.Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan LeukodystrophySeverity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids.Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge.Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.Neural-specific deletion of mitochondrial p32/C1qbp leads to leukoencephalopathy due to undifferentiated oligodendrocyte and axon degeneration.Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.Canavan disease - unusual imaging features in a child with mild clinical presentation.Structural modeling of p.V31F variant in the aspartoacylase gene.Brain Nat8l Knockdown Suppresses Spongiform Leukodystrophy in an Aspartoacylase-Deficient Canavan Disease Mouse Model.Atypical clinical and radiological course of a patient with Canavan disease.
P2860
Q27345414-9102150C-7258-4F81-8172-16314964D154Q31147424-E2B62F44-1ECC-422D-9720-0FBDEAE72D6DQ35899850-6AF1113F-7C2A-4190-BC94-103399C2C367Q36350060-6077DF94-ED58-49C8-A88D-24CED0FCC0AAQ37592141-12B74EE8-DFA5-4503-ACE1-8D234CD20FF9Q41960021-47AA5C38-D9AD-44A2-A9C9-63452EAB30D3Q43176453-E60E6E66-7053-46C1-966F-40E0EDE5244EQ43439006-8A305411-EC0E-4778-8835-B264DB83E084Q45934574-BC9FE99B-8FE8-4A2F-950E-785ADBD94F2CQ47112971-E0698656-3A6A-4824-A38B-B3FDFFEEC1ADQ47844285-919D5F92-89E6-453E-B38D-D056294ACAC5Q48614020-6BA605E3-0D69-4C28-8B9D-733CA6F62170Q48956853-4A5A162F-25A9-46B5-96CD-1032AAC5A55BQ49886923-64352ED2-D803-475C-9DF2-3BFC7340A4ABQ52146663-253D80D5-3601-42FE-A33A-BD4D708DF145
P2860
Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Canavan disease, a rare early- ...... ossible clinical interventions
@ast
Canavan disease, a rare early- ...... ossible clinical interventions
@en
Canavan disease, a rare early- ...... ossible clinical interventions
@nl
type
label
Canavan disease, a rare early- ...... ossible clinical interventions
@ast
Canavan disease, a rare early- ...... ossible clinical interventions
@en
Canavan disease, a rare early- ...... ossible clinical interventions
@nl
prefLabel
Canavan disease, a rare early- ...... ossible clinical interventions
@ast
Canavan disease, a rare early- ...... ossible clinical interventions
@en
Canavan disease, a rare early- ...... ossible clinical interventions
@nl
P3181
P1433
P1476
Canavan disease, a rare early- ...... ossible clinical interventions
@en
P2093
D N Guilfoyle
M H Baslow
P304
P3181
P356
10.1016/J.BIOCHI.2012.10.023
P407
P577
2013-04-01T00:00:00Z